These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16085886)

  • 1. Escherichia coli K1's capsule is a barrier to bacteriophage T7.
    Scholl D; Adhya S; Merril C
    Appl Environ Microbiol; 2005 Aug; 71(8):4872-4. PubMed ID: 16085886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Host Recognition Mechanism of the K1 Capsule-Specific Phage of
    Gong Q; Wang X; Huang H; Sun Y; Qian X; Xue F; Ren J; Dai J; Tang F
    J Virol; 2021 Aug; 95(18):e0092021. PubMed ID: 34191582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genome of bacteriophage K1F, a T7-like phage that has acquired the ability to replicate on K1 strains of Escherichia coli.
    Scholl D; Merril C
    J Bacteriol; 2005 Dec; 187(24):8499-503. PubMed ID: 16321955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structures of bacteriophages K1E and K1-5 explain processive degradation of polysaccharide capsules and evolution of new host specificities.
    Leiman PG; Battisti AJ; Bowman VD; Stummeyer K; Mühlenhoff M; Gerardy-Schahn R; Scholl D; Molineux IJ
    J Mol Biol; 2007 Aug; 371(3):836-49. PubMed ID: 17585937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli.
    Scholl D; Rogers S; Adhya S; Merril CR
    J Virol; 2001 Mar; 75(6):2509-15. PubMed ID: 11222673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli K1-specific bacteriophage CUS-3 distribution and function in phase-variable capsular polysialic acid O acetylation.
    King MR; Vimr RP; Steenbergen SM; Spanjaard L; Plunkett G; Blattner FR; Vimr ER
    J Bacteriol; 2007 Sep; 189(17):6447-56. PubMed ID: 17601779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.
    Weiss M; Denou E; Bruttin A; Serra-Moreno R; Dillmann ML; Brüssow H
    Virology; 2009 Oct; 393(1):16-23. PubMed ID: 19699505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The K1 capsule modulates trafficking of E. coli-containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells.
    Kim KJ; Elliott SJ; Di Cello F; Stins MF; Kim KS
    Cell Microbiol; 2003 Apr; 5(4):245-52. PubMed ID: 12675682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activities of bacteriophage depolymerase on bacterial polysaccharide: binding is essential but degradation is inhibitory in phage infection of K1-defective Escherichia coli.
    Pelkonen S; Aalto J; Finne J
    J Bacteriol; 1992 Dec; 174(23):7757-61. PubMed ID: 1447142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective synthesis and labeling of the polysialic acid capsule in Escherichia coli K1 strains with mutations in nanA and neuB.
    Vimr ER
    J Bacteriol; 1992 Oct; 174(19):6191-7. PubMed ID: 1400168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of the K1 capsule in invasive infections caused by Escherichia coli.
    Cross AS; Gemski P; Sadoff JC; Orskov F; Orskov I
    J Infect Dis; 1984 Feb; 149(2):184-93. PubMed ID: 6199436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype.
    Mushtaq N; Redpath MB; Luzio JP; Taylor PW
    Antimicrob Agents Chemother; 2004 May; 48(5):1503-8. PubMed ID: 15105097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.
    Bull JJ; Vimr ER; Molineux IJ
    Virology; 2010 Mar; 398(1):79-86. PubMed ID: 20006993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model.
    Bull JJ; Otto G; Molineux IJ
    Antimicrob Agents Chemother; 2012 Feb; 56(2):949-54. PubMed ID: 22106213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of colanic acid and serotype-specific capsular polysaccharides in Escherichia coli strains with group II K antigens.
    Keenleyside WJ; Bronner D; Jann K; Jann B; Whitfield C
    J Bacteriol; 1993 Oct; 175(20):6725-30. PubMed ID: 8407850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage.
    Qimron U; Marintcheva B; Tabor S; Richardson CC
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19039-44. PubMed ID: 17135349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection.
    Colino J; Outschoorn I
    Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage-encoded colanic acid-degrading enzyme permits lytic phage infection of a capsule-forming resistant mutant Escherichia coli strain.
    Kim MS; Kim YD; Hong SS; Park K; Ko KS; Myung H
    Appl Environ Microbiol; 2015 Feb; 81(3):900-9. PubMed ID: 25416767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 Escherichia coli strains.
    Kim KS; Cross AS; Kaufmann B; Zollinger W; Sadoff J
    Pediatr Res; 1990 Dec; 28(6):667-70. PubMed ID: 1704500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophage T7 DNA ejection into cells is initiated by an enzyme-like mechanism.
    Kemp P; Gupta M; Molineux IJ
    Mol Microbiol; 2004 Aug; 53(4):1251-65. PubMed ID: 15306026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.